Canada markets closed

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2600+0.0500 (+4.13%)
At close: 04:00PM EDT
1.2600 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 86.23M
Enterprise Value -32.45M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.70
Price/Book (mrq)0.55
Enterprise Value/Revenue -1.04
Enterprise Value/EBITDA 0.28

Trading Information

Stock Price History

Beta (5Y Monthly) 0.23
52-Week Change 3-85.76%
S&P500 52-Week Change 323.57%
52 Week High 311.1200
52 Week Low 30.5900
50-Day Moving Average 31.2210
200-Day Moving Average 33.6239

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 3860.19k
Shares Outstanding 571.26M
Implied Shares Outstanding 670.92M
Float 850.33M
% Held by Insiders 12.48%
% Held by Institutions 195.25%
Shares Short (Apr 15, 2024) 44.99M
Short Ratio (Apr 15, 2024) 46.68
Short % of Float (Apr 15, 2024) 48.11%
Short % of Shares Outstanding (Apr 15, 2024) 47.04%
Shares Short (prior month Mar 15, 2024) 45.12M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -283.15%
Operating Margin (ttm)-134.99%

Management Effectiveness

Return on Assets (ttm)-32.53%
Return on Equity (ttm)-49.88%

Income Statement

Revenue (ttm)31.25M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)126.60%
Gross Profit (ttm)N/A
EBITDA -117.56M
Net Income Avi to Common (ttm)-88.48M
Diluted EPS (ttm)-1.2700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)119.11M
Total Cash Per Share (mrq)1.68
Total Debt (mrq)3.5M
Total Debt/Equity (mrq)2.23%
Current Ratio (mrq)4.16
Book Value Per Share (mrq)2.22

Cash Flow Statement

Operating Cash Flow (ttm)-78.33M
Levered Free Cash Flow (ttm)-39.92M